v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 212 $ 212
Operating expenses:    
Research and development 2,871 5,725
General and administrative 6,074 4,157
Total operating expenses 8,945 9,882
Loss from operations (8,733) (9,670)
Other income:    
Interest income 201 644
Other income 254 174
Total other income, net 455 818
Loss before equity in losses of joint venture (8,278) (8,852)
Loss on investment in joint venture 0 587
Net loss $ (8,278) $ (9,439)
Net loss per common share, basic (in dollars per share) $ (1.46) $ (1.69)
Net loss per common share, diluted (in dollars per share) $ (1.46) $ (1.69)
Weighted-average common shares outstanding, basic (in shares) 5,688,584 5,597,528
Weighted-average common shares outstanding, diluted (in shares) 5,688,584 5,597,528
Other comprehensive loss:    
Net unrealized loss on marketable securities $ (17) $ (21)
Other comprehensive loss (17) (21)
Comprehensive loss (8,295) (9,460)
Collaboration and license revenue    
Revenue:    
Total revenue $ 212 $ 212